this matter. These authors note that in the context of their (cross sectional) analysis of levels of FEV, (as distinct from rate of loss in FEV, with age) allowance for an age dependent smoking effect explained more of the total variability in their data than a simple additive model. They add, however, that the relationship between dust exposure and FEV, was hardly altered by the way that smoking was taken into account. The latter finding is consistent with the results of other work,2 which show that the significant effect of dust exposure on FEV, in coalminers who smoke is statistically indistinguishable from the dust effect evident in miners who do not smoke.
Dr Oldham is right in his assumption that the paper by Rogan et al which I mentioned is that published in the British Journal of Industrial Medicine (his reference 3) (and I am sorry about the error in my earlier lists of references). He is right also to point out that the analyses described in that paper did not, on their own, demonstrate the association between dust exposure and FEV, separately in the 3005 men with category 0. However, Dr Jacobsen, a coauthor of the paper, has in subsequent work on the same data confirmed the significant relationships between dust exposure and FEV, in the 3005 men in category 0 (as well as in 2272 with no bronchitic symptoms, as first reported in 19733). The Persisting "asthma" in tropical pulmonary eosinophilia SIR,-We were very interested in the report by Dr DA Jones and his colleagues (September 1983, p 692) of tropical pulmonary eosinophilia simulating classical asthma in a 37 year old Indian man. We met the same problem in a 4 year old Indian girl who had been resident in France for one year. She was referred to our paediatric chest clinic with the diagnosis of asthma of two months' duration. After four months of oral bronchodilator treatment only partial improvement had been achieved and our attention was drawn to the unusual intensity of inspiratory crackles audible in the chest and to a leucocytosis varying from 8-2 to 22-4 x 109/l with 24-60% of eosinophils. The total serum immunoglobulin E concentration was 940 IU/ml (PRIST Phadebas). The chest radiographs were reviewed and found to show diffuse bilateral miliary mottling, predominant in the mid and lower zones. The filarial fluorescent antibody (FFA) test gave a positive result with a titre of 1/12 800. Specific dynamic compliance was decreased (48 ml/cm H2O/l at functional residual capacity; normal = 68).' Intradermal skin test responses to common inhaled allergens were negative.
During treatment with diethyl carbamazine in a total dose of 2-1 g (123 mg/kg) over 22 days, the serum IgE concentration peaked at 19 900 IU/ml and was still raised at 1100 IU/ml one year later. One month after completion of treatment the result of the FFA test was positive with a titre of 1/200, but specific dynamic compliance had returned to normal values. Chest radiographs showed clearing of the mottling six months after treatment had started, although blood eosinophilia persisted (1-1 x 109/ 1). Dyspnoea disappeared within a few weeks of starting treatment with diethyl carbamazine and bronchodilator drugs were discontinued. There has been no recurrence of symptoms during the three years that have followed. published by Hughes and Rumore as long ago as 1944,' the authors commented "The incidence of this condition cannot be estimated." None the less, among the 280 cadavers examined by them two cases of partial anomalous pulmonary venous connection were found, giving an incidence of 0.7%. They also pointed out that Adachi had found an exactly similar incidence in 1933.
The final point of this paper is that "no trustworthy estimation can be made of the incidence of anomalous pulmonary veins." However, their experience would suggest that they are not as uncommon as Dr Stewart and his colleagues suggest. It is also of interest that their second patient had azygos continuation of the inferior vena cava. This should raise the suspicion of left atrial isomerism (polysplenia). Do 
